FDA Grants Second Approval under the National Priority Voucher Pilot Program
For Immediate Release: February 26, 2026 The U.S. Food and Drug Administration today issued an approval for the lung cancer drug Hernexeos (zongertinib) as a part of the new Commissioner's National Priority Voucher (CNPV) pilot program. The application …